NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 218 filers reported holding NEVRO CORP in Q3 2020. The put-call ratio across all filers is 1.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,115,277 | -6.5% | 110,056 | +23.7% | 0.00% | 0.0% |
| Q2 2023 | $2,262,329 | -16.2% | 88,998 | +19.2% | 0.00% | 0.0% |
| Q1 2023 | $2,699,647 | +1.0% | 74,679 | +10.7% | 0.00% | 0.0% |
| Q4 2022 | $2,672,444 | -15.1% | 67,486 | -0.1% | 0.00% | 0.0% |
| Q3 2022 | $3,147,000 | +2.0% | 67,522 | -4.1% | 0.00% | 0.0% |
| Q2 2022 | $3,084,000 | -23.7% | 70,375 | +26.0% | 0.00% | 0.0% |
| Q1 2022 | $4,041,000 | -28.7% | 55,866 | -20.1% | 0.00% | -50.0% |
| Q4 2021 | $5,665,000 | -25.4% | 69,880 | +7.1% | 0.00% | 0.0% |
| Q3 2021 | $7,595,000 | -14.0% | 65,265 | +22.5% | 0.00% | -33.3% |
| Q2 2021 | $8,835,000 | -7.8% | 53,285 | -22.4% | 0.00% | -25.0% |
| Q1 2021 | $9,584,000 | -4.9% | 68,706 | +18.0% | 0.00% | 0.0% |
| Q4 2020 | $10,081,000 | +36.2% | 58,238 | +9.6% | 0.00% | +33.3% |
| Q3 2020 | $7,404,000 | +13.9% | 53,144 | -2.3% | 0.00% | 0.0% |
| Q2 2020 | $6,502,000 | +221.2% | 54,420 | +171.7% | 0.00% | +200.0% |
| Q1 2020 | $2,024,000 | -19.6% | 20,026 | -6.4% | 0.00% | 0.0% |
| Q4 2019 | $2,516,000 | +45.6% | 21,400 | +6.4% | 0.00% | 0.0% |
| Q3 2019 | $1,728,000 | +94.4% | 20,120 | +46.8% | 0.00% | – |
| Q2 2019 | $889,000 | +9.3% | 13,707 | +5.4% | 0.00% | – |
| Q1 2019 | $813,000 | +62.0% | 13,005 | +0.9% | 0.00% | – |
| Q4 2018 | $502,000 | -10.2% | 12,886 | +31.2% | 0.00% | – |
| Q3 2018 | $559,000 | -28.8% | 9,821 | 0.0% | 0.00% | -100.0% |
| Q2 2018 | $785,000 | -13.4% | 9,821 | -6.1% | 0.00% | 0.0% |
| Q1 2018 | $906,000 | +6.5% | 10,454 | -14.9% | 0.00% | 0.0% |
| Q4 2017 | $851,000 | -17.6% | 12,285 | +7.9% | 0.00% | 0.0% |
| Q3 2017 | $1,033,000 | +28.2% | 11,389 | +5.6% | 0.00% | 0.0% |
| Q2 2017 | $806,000 | +6.1% | 10,787 | +32.6% | 0.00% | 0.0% |
| Q1 2017 | $760,000 | +35.5% | 8,137 | +5.4% | 0.00% | 0.0% |
| Q4 2016 | $561,000 | +3.1% | 7,719 | +46.2% | 0.00% | 0.0% |
| Q3 2016 | $544,000 | +49.0% | 5,278 | +4.1% | 0.00% | – |
| Q2 2016 | $365,000 | +60.1% | 5,070 | +23.8% | 0.00% | – |
| Q1 2016 | $228,000 | +7.5% | 4,094 | +28.7% | 0.00% | – |
| Q4 2015 | $212,000 | +165.0% | 3,182 | +80.3% | 0.00% | – |
| Q3 2015 | $80,000 | -9.1% | 1,765 | +6.5% | 0.00% | – |
| Q2 2015 | $88,000 | +700.0% | 1,657 | +623.6% | 0.00% | – |
| Q1 2015 | $11,000 | – | 229 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tiger Eye Capital LLC | 239,122 | $41,392,000 | 8.25% |
| Integral Health Asset Management, LLC | 88,000 | $15,233,000 | 4.53% |
| Iron Triangle Partners LP | 168,761 | $29,213,000 | 3.79% |
| Eos Focused Equity Management, L.P. | 14,002 | $2,424,000 | 2.37% |
| PFM Health Sciences, LP | 311,940 | $53,997,000 | 1.90% |
| Perceptive Advisors | 977,565 | $169,217,000 | 1.82% |
| Rock Springs Capital Management LP | 395,000 | $68,375,000 | 1.45% |
| Lisanti Capital Growth, LLC | 54,302 | $9,400,000 | 1.30% |
| HealthCor Management, L.P. | 156,046 | $27,012,000 | 1.04% |
| FRED ALGER MANAGEMENT, LLC | 2,136,612 | $369,848,000 | 0.96% |